Systematic Financial Management LP Purchases 15,462 Shares of Encompass Health Corporation $EHC

Systematic Financial Management LP lifted its position in shares of Encompass Health Corporation (NYSE:EHC) by 3.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 440,752 shares of the company’s stock after buying an additional 15,462 shares during the period. Encompass Health comprises approximately 1.1% of Systematic Financial Management LP’s portfolio, making the stock its 19th biggest holding. Systematic Financial Management LP’s holdings in Encompass Health were worth $46,782,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. WPG Advisers LLC lifted its holdings in shares of Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after acquiring an additional 137 shares during the period. Westside Investment Management Inc. lifted its holdings in shares of Encompass Health by 56.7% in the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after acquiring an additional 101 shares during the last quarter. Flagship Harbor Advisors LLC bought a new position in shares of Encompass Health in the fourth quarter worth about $37,000. Assetmark Inc. lifted its holdings in shares of Encompass Health by 88.1% in the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after acquiring an additional 140 shares during the last quarter. Finally, Root Financial Partners LLC bought a new position in shares of Encompass Health in the third quarter worth about $39,000. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the subject of a number of research reports. Barclays dropped their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Leerink Partners set a $152.00 target price on shares of Encompass Health in a report on Friday. Finally, Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $145.29.

Encompass Health Stock Performance

Encompass Health stock opened at $105.04 on Friday. The business has a 50 day moving average of $102.86 and a 200-day moving average of $105.81. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17. The company has a market capitalization of $10.42 billion, a P/E ratio of 17.54, a P/E/G ratio of 2.29 and a beta of 0.72.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the prior year, the firm posted $1.37 earnings per share. The firm’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities research analysts predict that Encompass Health Corporation will post 5.96 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is currently 12.69%.

Insider Activity at Encompass Health

In other news, Treasurer Edmund Fay sold 11,937 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer owned 89,325 shares of the company’s stock, valued at $9,557,775. This represents a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This represents a 2.68% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.80% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.